<code id='64CB5D4110'></code><style id='64CB5D4110'></style>
    • <acronym id='64CB5D4110'></acronym>
      <center id='64CB5D4110'><center id='64CB5D4110'><tfoot id='64CB5D4110'></tfoot></center><abbr id='64CB5D4110'><dir id='64CB5D4110'><tfoot id='64CB5D4110'></tfoot><noframes id='64CB5D4110'>

    • <optgroup id='64CB5D4110'><strike id='64CB5D4110'><sup id='64CB5D4110'></sup></strike><code id='64CB5D4110'></code></optgroup>
        1. <b id='64CB5D4110'><label id='64CB5D4110'><select id='64CB5D4110'><dt id='64CB5D4110'><span id='64CB5D4110'></span></dt></select></label></b><u id='64CB5D4110'></u>
          <i id='64CB5D4110'><strike id='64CB5D4110'><tt id='64CB5D4110'><pre id='64CB5D4110'></pre></tt></strike></i>

          Home / fashion / knowledge

          knowledge


          knowledge

          author:comprehensive    Page View:11192
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In